342 related articles for article (PubMed ID: 19055753)
1. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
[TBL] [Abstract][Full Text] [Related]
2. Porcine Invariant Natural Killer T Cells: Functional Profiling and Dynamics in Steady State and Viral Infections.
Schäfer A; Hühr J; Schwaiger T; Dorhoi A; Mettenleiter TC; Blome S; Schröder C; Blohm U
Front Immunol; 2019; 10():1380. PubMed ID: 31316500
[TBL] [Abstract][Full Text] [Related]
3. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
4. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
Yang G; Artiaga BL; Lewis ST; Driver JP
Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
[TBL] [Abstract][Full Text] [Related]
5. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.
Gentilini MV; Pérez ME; Fernández PM; Fainboim L; Arana E
Cancer Immunol Immunother; 2016 May; 65(5):551-62. PubMed ID: 26969612
[TBL] [Abstract][Full Text] [Related]
6. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
7. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
Front Immunol; 2019; 10():2355. PubMed ID: 31649670
[TBL] [Abstract][Full Text] [Related]
8. Elevated Hepatic CD1d Levels Coincide with Invariant NKT Cell Defects in Chronic Hepatitis B Virus Infection.
Tan X; Ding Y; Zhu P; Dou R; Liang Z; Yang D; Huang Z; Wang W; Wu X; Weng X
J Immunol; 2018 May; 200(10):3530-3538. PubMed ID: 29643189
[TBL] [Abstract][Full Text] [Related]
9. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
[TBL] [Abstract][Full Text] [Related]
10. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
[TBL] [Abstract][Full Text] [Related]
12. A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.
Birkholz AM; Girardi E; Wingender G; Khurana A; Wang J; Zhao M; Zahner S; Illarionov PA; Wen X; Li M; Yuan W; Porcelli SA; Besra GS; Zajonc DM; Kronenberg M
J Immunol; 2015 Aug; 195(3):924-33. PubMed ID: 26078271
[TBL] [Abstract][Full Text] [Related]
13. Impact of Th1/Th2 cytokine polarity induced by invariant NKT cells on the incidence of pregnancy loss in mice.
Hoya M; Nagamatsu T; Fujii T; Schust DJ; Oda H; Akiba N; Iriyama T; Kawana K; Osuga Y; Fujii T
Am J Reprod Immunol; 2018 Mar; 79(3):. PubMed ID: 29363849
[TBL] [Abstract][Full Text] [Related]
14. Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C.
Speak AO; Platt N; Salio M; te Vruchte D; Smith DA; Shepherd D; Veerapen N; Besra GS; Yanjanin NM; Simmons L; Imrie J; Wraith JE; Lachmann RH; Hartung R; Runz H; Mengel E; Beck M; Hendriksz CJ; Porter FD; Cerundolo V; Platt FM
Eur J Immunol; 2012 Jul; 42(7):1886-92. PubMed ID: 22585405
[TBL] [Abstract][Full Text] [Related]
15. Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
Wang Y; Sedimbi SK; Löfbom L; Besra GS; Porcelli SA; Cardell SL
Front Immunol; 2019; 10():352. PubMed ID: 30881361
[TBL] [Abstract][Full Text] [Related]
16. Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
Hsu CY; Chueh YS; Kuo ML; Lee PT; Hsiao HS; Huang JL; Lin SJ
PLoS One; 2021; 16(12):e0261727. PubMed ID: 34936686
[TBL] [Abstract][Full Text] [Related]
17. CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice.
Gonzalez Roldan N; Orinska Z; Ewers H; Bulfone-Paus S
Eur J Immunol; 2016 Feb; 46(2):432-9. PubMed ID: 26564814
[TBL] [Abstract][Full Text] [Related]
18. Novel in vitro invariant natural killer T cell functional assays.
Balasko A; Graydon C; Fowke KR
J Immunol Methods; 2021 Dec; 499():113171. PubMed ID: 34706265
[TBL] [Abstract][Full Text] [Related]
19. The GM2 ganglioside inhibits iNKT cell responses in a CD1d-dependent manner.
Pereira CS; Ribeiro H; Pérez-Cabezas B; Cardoso MT; Alegrete N; Gaspar A; Leão-Teles E; Macedo MF
Mol Genet Metab; 2018 Sep; 125(1-2):161-167. PubMed ID: 30030044
[TBL] [Abstract][Full Text] [Related]
20. IL-7 During Antigenic Stimulation Using Allogeneic Dendritic Cells Promotes Expansion of CD45RA
Trujillo-Ocampo A; Cho HW; Clowers M; Pareek S; Ruiz-Vazquez W; Lee SE; Im JS
Front Immunol; 2020; 11():567406. PubMed ID: 33329531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]